Skip to main content

MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.

Publication ,  Journal Article
Streicher, JM; Ren, S; Herschman, H; Wang, Y
Published in: Circ Res
April 30, 2010

RATIONALE: Activation of p38 mitogen-activated protein kinase (MAPK) has a significant impact on cardiac gene expression, contractility, extracellular matrix remodeling, and inflammatory response in heart. The p38 kinase pathway also has a controversial role in cardiac hypertrophy. MAPK-activated protein kinase-2 (MK2) is a well-established p38 downstream kinase, yet its contribution to p38-mediated pathological response in heart has not been investigated. OBJECTIVE: We examined the specific contribution of MK2 to the pathological remodeling induced by p38. METHODS AND RESULTS: We used a cardiomyocyte specific and inducible transgenic approach to determine the functional and molecular impact of acute activation of the p38 pathway in heart in either a MK2 wild-type or a MK2-null background. p38 activation in wild-type mice led to a rapid onset of lethal cardiomyopathy associated with cardiomyocyte hypertrophy, interstitial fibrosis, and contractile dysfunction. Inactivation of MK2 partially but significantly reduced cardiomyocyte hypertrophy, improved contractile performance, and prevented early lethality. MK2 inactivation had no effect on the mRNA levels of hypertrophic marker genes or the proinflammatory gene cyclooxygenase (COX)-2. However, MK2 had a major role in COX-2 protein synthesis without affecting the mRNA level or protein stability. CONCLUSIONS: p38 activity in adult myocytes can contribute to pathological hypertrophy and remodeling in adult heart and that MK2 is an important downstream molecule responsible for specific features of p38-induced cardiac pathology.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circ Res

DOI

EISSN

1524-4571

Publication Date

April 30, 2010

Volume

106

Issue

8

Start / End Page

1434 / 1443

Location

United States

Related Subject Headings

  • p38 Mitogen-Activated Protein Kinases
  • Ventricular Remodeling
  • Transfection
  • Time Factors
  • Signal Transduction
  • Rats, Sprague-Dawley
  • Rats
  • RNA, Messenger
  • Protein Serine-Threonine Kinases
  • Myocytes, Cardiac
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Streicher, J. M., Ren, S., Herschman, H., & Wang, Y. (2010). MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ Res, 106(8), 1434–1443. https://doi.org/10.1161/CIRCRESAHA.109.213199
Streicher, John M., Shuxun Ren, Harvey Herschman, and Yibin Wang. “MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.Circ Res 106, no. 8 (April 30, 2010): 1434–43. https://doi.org/10.1161/CIRCRESAHA.109.213199.
Streicher JM, Ren S, Herschman H, Wang Y. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ Res. 2010 Apr 30;106(8):1434–43.
Streicher, John M., et al. “MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.Circ Res, vol. 106, no. 8, Apr. 2010, pp. 1434–43. Pubmed, doi:10.1161/CIRCRESAHA.109.213199.
Streicher JM, Ren S, Herschman H, Wang Y. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ Res. 2010 Apr 30;106(8):1434–1443.

Published In

Circ Res

DOI

EISSN

1524-4571

Publication Date

April 30, 2010

Volume

106

Issue

8

Start / End Page

1434 / 1443

Location

United States

Related Subject Headings

  • p38 Mitogen-Activated Protein Kinases
  • Ventricular Remodeling
  • Transfection
  • Time Factors
  • Signal Transduction
  • Rats, Sprague-Dawley
  • Rats
  • RNA, Messenger
  • Protein Serine-Threonine Kinases
  • Myocytes, Cardiac